Sae Byul Lee
Overview
Explore the profile of Sae Byul Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Yoo T, Lee S, Chung I, Kim H, Ko B, et al.
J Breast Cancer
. 2025 Mar;
28(1):11-22.
PMID: 40047087
Purpose: This study analyzed the pathological complete response (pCR) rates, long-term outcomes, and biological features of human epidermal growth factor receptor 2 (HER2)-zero, HER2-low, and HER2-positive breast cancer patients undergoing...
2.
Shin Y, Lee S, Jeong H, Ahn J, Jung K, Kim S, et al.
Cancer Res Treat
. 2025 Mar;
PMID: 40045569
Purpose: Although HER2 positivity is prevalent in microinvasive breast cancer (MIBC), data focused on HER2-positive MIBC are limited. We investigated the clinical course and long-term outcomes of HER2-positive MIBC and...
3.
Lee S, Kim J, Chung I, Kim H, Lee J, Son B, et al.
Sci Rep
. 2025 Jan;
15(1):12.
PMID: 39747503
We investigated the safety and performance of the Da Vinci SP single-port robot (SP robot) in nipple-sparing mastectomy (NSM) with immediate reconstruction. Medical records of 60 women aged ≥ 19...
4.
Kim A, Lee S, Yoo T, Kim J, Chung I, Kim H, et al.
Sci Rep
. 2025 Jan;
15(1):86.
PMID: 39747396
In breast-conserving surgery (BCS), clear resection margins are crucial to prevent recurrence. Accurate imaging is vital for precise BCS, with MRI being the most accurate. However, MRI has limitations in...
5.
Lee Y, Baek S, Lee J, Lee Y, Yoo T, Kim J, et al.
Clin Breast Cancer
. 2024 Dec;
PMID: 39741092
Aim: To compare menopausal symptoms between tamoxifen alone and tamoxifen with ovarian function suppression (OFS) over 12 months, identifying related factors. Methods: This prospective, observational study included 209 premenopausal patients...
6.
Kang E, Cheun J, Lee J, Koh J, Lee H, Park J, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727016
Purpose: Multigene assays guide treatment decisions in early-stage hormone receptor-positive breast cancer. OncoFREE, a next-generation sequencing assay using 179 genes, was developed for this purpose. This study aimed to evaluate...
7.
Cha C, Park C, Shin H, Han J, Choi J, Kim J, et al.
J Breast Cancer
. 2024 Dec;
27(6):351-361.
PMID: 39622507
The Korean Breast Cancer Society (KBCS) has collected nationwide registry data on clinicopathologic characteristics and treatment since 1996. This study aimed to analyze the clinical characteristics of breast cancer in...
8.
Kook Y, Lee Y, Chu C, Jang J, Baek S, Bae S, et al.
Breast Cancer Res
. 2024 Nov;
26(1):164.
PMID: 39593071
No abstract available.
9.
Kook Y, Lee Y, Chu C, Jang J, Baek S, Bae S, et al.
Breast Cancer Res
. 2024 Nov;
26(1):154.
PMID: 39506855
Background: HER2-positivity is an essential marker for therapeutic decisions, while HER2 expression is heterogenous. In recent years, there has been increasing recognition of a subgroup of breast cancer patients who...
10.
Ryu J, Hyung J, Han S, Jeong J, Lee S, Yoo T, et al.
J Nucl Med
. 2024 Oct;
65(11):1689-1694.
PMID: 39362758
The clinical impact of 16α-F-fluoro-17β-estradiol (F-FES) PET/CT on patient management has not been well investigated. The aim of this study was to assess the clinical impact of F-FES PET/CT on...